in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Nycomed JV Opens API Facility in India
2:47 AM MDT | September 29, 2010 | Deepti Ramesh
Nycomed (Zurich, Switzerland) says its Zydus Nycomed (Navi Mumbai, India) joint venture with Zydus Cadila (Ahmedabad, India) has commissioned its expanded active pharmaceutical ingredients (API) manufacturing facility at Navi Mumbai, and the company is expected to start commercial production of APIs by December. The plant will initially manufacture pantoprazole, urapidil and lornoxicam, and by 2011 it will produce eight additional APIs. Zydus Nycomed is a 50-50 jv, which was formed in 1998. Nycomed had announced in 2008 that it plans to transfer production of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee